FREMONT, Calif. — Neuralink says a participant in its Blindsight trial has read individual letters produced directly by the company's visual-cortex implant, a step that moves the device from perceiving isolated flashes of light toward conveying usable visual information.
The result, shared by the company this week, represents one of the clearest signs yet that a brain implant can begin to substitute for lost sight. In the test, the implant stimulated the visual cortex in patterns that the participant — blind for years — was able to interpret as distinct shapes and, ultimately, letters.
From Points of Light to Patterns
Blindsight works by bypassing the eyes entirely, writing visual signals straight into the brain region that processes sight. Early participants described seeing scattered points of light, the raw building blocks of artificial vision. The new milestone shows those points being arranged into patterns coherent enough to recognize, building directly on the first successful Blindsight test earlier this month.
Engineers achieved the jump by increasing the number of stimulation sites and refining the software that maps a camera's input onto the cortex. The approach is iterative: as the electrode count and signal processing improve, the resolution of the artificial image climbs with them.
A Fast-Moving Trial
The Blindsight progress comes as Neuralink's broader human program accelerates. The company recently marked its 10th human implant as the trial gathered pace, spanning participants working on motor control, communication, and now vision. Each new implant feeds data back into the system, sharpening the algorithms that every participant relies on.